When a patient’s neuropathic symptoms are manifested in the form of physical pain, the result is considered “chronic pain.” Neuropathy and neuropathic pain have no cure. In fact, modern day medical research into these disorders exists to better the lives of those patients suffering from these afflictions. Nevertheless, doctors and patients are looking at medical marijuana as non-addictive.
The legislation, HB 1251, would permit the use of non-hallucinogenic marijuana or cannabis extracts known as cannabidiol oil or THC-A oil to treat any diagnosed condition or disease. Scientific studies indicate that the oils can reduce nausea and alleviate pain, and also may slow the growth of and kill some cancer cells.
Research suggests CBD may reduce chronic inflammation and pain, and users have also reported a reduction in anxiety, mood symptoms and insomnia.
Studies have also suggested benefits in the treatment of Alzheimer’s, arthritis, cancer and epilepsy, with research ongoing.
Cannabinoids appear to possess many potential medical uses, which may extend to pain control. A narrative review of the literature has found a variety of studies testing botanical and synthetic cannabinoids in different pain syndromes (acute pain, cancer pain, chronic noncancer pain, fibromyalgia pain, migraine, neuropathic pain, visceral pain, and others). Results from these studies are mixed; cannabinoids appear to be most effective in controlling neuropathic pain, allodynia, medication-rebound headache, and chronic noncancer pain. A great deal more remains to be elucidated about cannabinoids which may emerge to play an important role in the treatment of neuropathic and possibly other painful conditions. There remains a great deal more to learn about the role of cannabinoids in pain management.
Medical marijuana continues to gain acceptance and become legalized in many states. Various species of the marijuana plant have been cultivated, and this plant can contain up to 100 active compounds known as cannabinoids. Two cannabinoids seem the most clinically relevant: Δ9-tetrahydrocannabinol (THC), which tends to produce the psychotropic effects commonly associated with marijuana, and cannabidiol (CBD), which may produce therapeutic effects without appreciable psychoactive properties. Although there is still a need for randomized controlled trials, preliminary studies have suggested that medical marijuana and related cannabinoids may be beneficial in treating people with chronic pain, inflammation, spasticity and other conditions.
The Labour-led Government will act on making medical cannabis more accessible next week. But instead of supporting an existing Bill in the House, the Government will introduce its own legislation. Labour campaigned on making medicinal cannabis available for people with terminal illness or in chronic pain, promising to introduce the legislation within its first 100…
Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives. The clinically and statistically significant evidence of an association between medical cannabis programme enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.
Anxiety and migraine sufferers may get a chance to use medical cannabis as a treatment in the Garden State New Jersey’s notoriously strict medical marijuana program may be on the road to expansion, thanks to the approval of five new ailments as qualifying conditions for medical cannabis by state regulators. Patch reports that the state’s Medicinal Marijuana Review Panel…
A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds. The U.S. Department of Veterans Affairs (VA) “is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD given…
It will be helpful to patients if they can be provided practical and accurate information about what is and is not known about this treatment. As medical marijuana penetrates mainstream medical practice in the United States and elsewhere, awareness of the potential benefits, potential risks, local laws governing its use for treatment or chronic pain…